SPDR S&P 500 ETF Trust (SPY)
Index – USA
On Friday, September 13th, U.S. markets closed higher as rising bets on a potential 50-basis point interest rate cut by the Federal Reserve boosted optimism. Small-cap stocks, particularly sensitive to rate changes, outperformed as hopes for a larger cut increased. Earlier today, Dow futures were up 0.16%, S&P 500 futures rose 0.03%, and Nasdaq 100 Futures fell 0.13%..
- STOCK – Support: 560
- STOCK – Resistance: 564
Palantir Technologies (PLTR)
Software – Colorado USA
PTLR continues to see volatility after the company was added to the S&P 500. Volume has slowed on the daily but still pushing upwards.
- STOCK – ATR: 1.42
- STOCK – RSI daily: 73.197
- STOCK – Support: 35
- STOCK – Resistance: 36
Nucana (NCNA)
Biotechnology – Edinburgh
NuCana presented final data from Phase 2 Nutide:701 study at ESMO Congress on NUC-7738 in combination with pembrolizumab for patients with metastatic melanoma who were refractory to or had relapsed on prior PD-1 inhibitor therapy. The market has been taking the news as positive in the premarket. Bit of a broken chart for robust historical levels. Tiny low float so volatility will be very high.
- STOCK – ATR: 0.84
- STOCK – RSI daily: 37.50
- STOCK – Resistance: 7.50, 8.00, 10.79
- STOCK – Support: 6.95, 5, 4.58
Zentalis Pharmaceutical (ZNTL)
Biotechnology – New York USA
U.S. Food and Drug Administration (FDA) has lifted the partial clinical hold on studies of azenosertib, the Company’s novel, selective, and orally bioavailable inhibitor of WEE1. Bit beat down on the daily after a big sell off 6/18. Lower float so definitely can gain momentum if buying steps in.
- STOCK – ATR: 0.28
- STOCK – RSI daily: 46.63
- STOCK – Support: 4.3, 3.75, 3.4
- STOCK – Resistance: 4.84, 6.43, 8.25